12 / November / 2024 The importance of health policies based on data science Despite the vast amount of data on the public health system, governments rarely uses these resources to develop and improve public policies Por Fabio Kon
08 / November / 2024 EMBRAPII and Einstein issue a call for advanced therapies The call for proposals intends to support startups and researchers looking to undertake projects in the field of advanced therapies Por Editorial staff
13 / September / 2024 Bruce Lewenstein: Science communication is part of a researcher’s job According to a professor at Cornell University in the US, seeking diverse voices within science communication requires introspection from scientists and communicators Por Letícia Naísa
02 / September / 2024 Telemedicine guidelines reduce unnecessary prescriptions Study shows that the adoption of specific care guidelines reduced the prescription of antibiotics and antimicrobials for COVID-19 patients Por Editorial staff
23 / August / 2024 AI increases colonoscopy rates in the US New York study used digital technology to identify cancer patients who missed colonoscopy exams Por Editorial staff
21 / August / 2024 The atlas that could revolutionize medicine An international consortium, supported by Brazilian researchers, reveals details of the human body’s molecular composition and operations at a cellular level Por Gilberto Stam
09 / August / 2024 Bioethics and AI: what role do clinicians and patients play? Researchers identify problems with the use of programs such as ChatGPT in the clinician-patient relationship and suggest how to make better use of AI tools Por Editorial staff
23 / July / 2024 Equality of access to scientific data Dutch initiative aims to encourage raw research data sharing to ensure replication of studies Por Editorial staff
02 / July / 2024 We need to steer technological change The innovations we need cannot depend solely on spontaneous discoveries prompted by curiosity Por André Tortato Rauen
12 / June / 2024 COVID-19: High levels of immunity hinder clinical trials Clinical trials conducted in 2021 and 2022 were unable to find a dosage of the SARS-CoV-2 virus capable of infecting volunteers in challenge studies Por Editorial staff
